Akasha Naturals Review 2026: A Mood Capsule Containing Both a Serotonin and a Dopamine Precursor

**SeroRestore Serotonin Support**, $54.75 for 30 capsules, is marketed for "calm, positive mood, and emotional balance," focus, and sleep. Akasha lists its contents plainly, and we are grateful it does: **5-HTP, active vitamin B6 (pyridoxal-5-phosphate), berberine HCl, Mucuna pruriens and evodiamine**, with vitamin C. Take those one at a time. **5-HTP** is the immediate precursor to serotonin. It is the active mechanism of the product and the reason for the name. **Mucuna pruriens** is a tropical legume whose seeds contain **L-DOPA** — the direct precursor to dopamine, and the same molecule as the primary Parkinson's disease drug, levodopa. Clinical trials in Parkinson's show mucuna can raise dopamine comparably to pharmaceutical levodopa. This is not a gentle botanical; it is a pharmacologically active dopaminergic agent. **Berberine HCl** is a significant inhibitor of **CYP3A4 and P-glycoprotein** — the enzyme and transporter handling a large share of prescription drug metabolism — and it lowers blood glucose. **Evodiamine** is a TRPV1 agonist used as a thermogenic. So a single capsule delivers a serotonin precursor, a dopamine precursor, a metabolic enzyme inhibitor and a thermogenic. To a customer who has gone looking for something called "Serotonin Support."

There is a second problem with the mucuna specifically, and it applies to every brand that uses it. **The L-DOPA content of mucuna supplements is notoriously inconsistent.** It varies with seed source, cultivar and extraction method, and quality testing has found products containing levodopa **up to 22 times higher than the labelled amount**. Think about what that means in this product. You are taking an unstated quantity of a drug precursor, from a botanical whose active content is known to vary by more than an order of magnitude between products, in a capsule that also contains a serotonin precursor and a CYP3A4 inhibitor, bought over the counter for mood. None of that requires anything to have gone wrong at Akasha. Their material may be well-sourced and accurately dosed. The point is that a buyer has no way to know, and neither does the clinician they would need to consult about it. We should be fair about the counterweight: **Akasha tells you the mucuna is there.** A great many mood supplements would have buried the same ingredient list inside a "Neurotransmitter Support Blend" and disclosed nothing. Naming 5-HTP, berberine, mucuna and evodiamine explicitly is the honest thing to do, and it is why this review can exist. Our criticism is of the formulation choice, not of the transparency.

Akasha Naturals is not a standalone supplement brand that happens to have a doctor's endorsement. It is the retail line of a working medical clinic, and the company describes the supplements as having been "a major component of their success in successfully treating patients at the Akasha Center." That arrangement has an established ethical framework, and it is worth applying it plainly. The **AMA Code of Medical Ethics, Opinion 9.6.4 (Sale of Health-Related Products)**, addresses precisely this. Its position is that physician sale of health-related products **"raises ethical concerns about financial conflict of interest, risks placing undue pressure on the patient, threatens to erode patient trust, undermine the primary obligation of physicians to serve the interests of their patients before their own, and demean the profession of medicine."** The opinion sets out what physicians who do sell products owe their patients. They should **"offer only products whose claims of benefit are based on peer-reviewed literature or other sources of scientific review of efficacy that are unbiased, sound, systematic, and reliable,"** and **"should not offer products whose claims to benefit lack scientific validity."** It also notes that distributing products free or at cost removes the financial conflict, and that sales should be limited to products serving patients' immediate and pressing needs. Akasha sells 57 products at retail, online, to the general public as well as to its patients. A direct-to-consumer supplement line is meaningfully different from handing a bottle across the exam room — the pressure dynamic is weaker when nobody is sitting in front of their doctor. But the clinic's own patients are plainly part of the channel, and the "scientific validity" test in that opinion is the right one to hold the catalogue against. Which brings us to the parts of the catalogue that do not meet it.

**"The first dietary supplement line to be developed by an interdisciplinary team of board-certified medical doctors and licensed, recognized practitioners."** This is not correct. Practitioner-channel supplement lines developed by and for clinicians substantially predate Akasha's 2002 founding. **Standard Process** dates to 1929. **Metagenics** was founded in 1983, **Thorne** in 1984, **Designs for Health** in 1989, **Pure Encapsulations** in 1991 — all built expressly around healthcare practitioners, with medical and scientific advisory involvement, and all established well before Akasha existed. The practitioner channel was already a mature segment by 2002. It is a superlative that adds nothing. The genuine claim — a supplement line formulated inside a long-running integrative clinic by a credentialed physician — is a good one on its own and does not need "first" attached to it. **"Our evidence-based discipline" alongside anthroposophic medicine.** Akasha describes its team as including practitioners in "Chinese medicine, naturopathy, **anthroposophic medicine**, nutritional therapy, and more," in the same passage that invokes an evidence-based discipline. Anthroposophic medicine is the system derived from Rudolf Steiner's spiritual philosophy in the 1920s. It is built on concepts such as the etheric and astral bodies, and its therapeutic logic follows from that metaphysics rather than from clinical trial evidence. Whatever one thinks of it, it is not evidence-based medicine, and it is not compatible with the phrase sitting next to it. A brand may reasonably offer integrative traditions; presenting them as interchangeable with an evidence base is where the positioning breaks. **The cleanse programmes.** The **Advanced Akasha Reset (21-day) is $485** and the **Essential Akasha Reset is $275**, alongside AdvaCleanse Daily Detox at $68 and InflaCleanse Plus at $93.75. AdvaCleanse's own description is more careful than most — it talks about supporting Phase I and Phase II liver detoxification enzymes, which is at least real biochemistry rather than vague "toxins" language. But the underlying position stands: a healthy liver detoxifies continuously without assistance, there is no good evidence that supplements improve that in a healthy person, and $485 for 21 days is a great deal of money for a proposition the evidence does not support.

Most of the range is unremarkable in a good way — ordinary, sensible formulations at premium-but-not-absurd prices.

**Akasha Naturals may suit you if:** you are an existing Akasha Center patient whose clinician has recommended something specific, which is the context this line was actually built for; you want straightforward single-nutrient products in good forms — the magnesium glycinate, the vitamin D with K2, the collagen — and the premium does not bother you; or you value that a credentialed physician stands behind the formulations and that the ingredients are named rather than hidden. **Do not buy SeroRestore if:** you take any antidepressant, triptan, tramadol, lithium or St John's wort, because of the 5-HTP; you take a non-selective MAOI, because Mucuna pruriens plus MAO inhibition is a recognised hypertensive crisis risk; you take any Parkinson's medication containing L-DOPA; or you take prescription drugs metabolised through CYP3A4, which is a very large category. In practice, that means: ask a pharmacist before this specific product, every time. **Look elsewhere generally if:** you are drawn to the $275–$485 cleanse programmes, which are the least defensible thing in the catalogue; you want published third-party certificates of analysis, which we did not find; or you were persuaded by the "first supplement line" claim, which is not accurate. **And if what you actually want is help with mood:** low mood that persists is worth a proper assessment. It has treatable causes that a capsule does not address — thyroid disease, B12 and vitamin D deficiency, sleep apnoea, anaemia, and medication side effects among them — and the treatments that work for depression have evidence behind them that no serotonin-precursor supplement can match. A clinic like Akasha is well placed to do that assessment. That is a better use of it than the supplement.

**Is Akasha Naturals legitimate?** Yes. It is the supplement line of the Akasha Center for Integrative Medicine, a Santa Monica clinic operating since 2002, founded by Edison de Mello, MD, PhD, who is board certified in integrative medicine by the American Board of Integrative Medicine and licensed as a psychotherapist in California. Our concerns are about specific formulations and claims, not about whether the company and clinic are real. **What is in SeroRestore?** 5-HTP, active vitamin B6 (pyridoxal-5-phosphate), berberine HCl, Mucuna pruriens, evodiamine and vitamin C. That means the capsule contains both a serotonin precursor (5-HTP) and a dopamine precursor (L-DOPA, from mucuna), plus a CYP3A4 and P-glycoprotein inhibitor. **Is it safe to take SeroRestore with an antidepressant?** Ask your prescriber before you do. 5-HTP raises serotonin syndrome risk with SSRIs, SNRIs, MAOIs, tricyclics, triptans, tramadol and St John's wort. Separately, Mucuna pruriens as an L-DOPA source combined with a non-selective MAOI can cause hypertensive crisis. Both mechanisms are relevant to the people most likely to buy a mood supplement. **How much L-DOPA is in it?** Unstated, and this is a category-wide problem rather than an Akasha-specific one. Levodopa content in mucuna supplements varies substantially with seed source and extraction, and testing has found products with up to 22 times the labelled amount. **Was Akasha really the first physician-formulated supplement line?** No. Standard Process dates to 1929, Metagenics to 1983, Thorne to 1984, Designs for Health to 1989 and Pure Encapsulations to 1991 — all practitioner-channel lines developed with clinical input, all well before Akasha's 2002 founding. **Is it a conflict of interest for a clinic to sell supplements?** It is a recognised one. AMA Code of Medical Ethics Opinion 9.6.4 states that physician sale of health-related products raises financial conflict-of-interest concerns and can place undue pressure on patients, and requires that physicians offer only products whose claimed benefits rest on sound scientific review — and not offer products whose claims lack scientific validity. **Are the Akasha Reset cleanses worth $275–$485?** We would not buy them. A healthy liver detoxifies continuously without supplementation, and there is no good evidence that a cleanse programme improves that. **Are the products third-party tested?** We did not find published certificates of analysis or third-party test results on the site. If that matters to you, ask for a lot-specific COA before ordering.